UPC (Universe Pharmaceuticals Inc. Class A Ordinary Shares) Stock Analysis - Insider Trades

Universe Pharmaceuticals Inc. Class A Ordinary Shares (UPC) is a publicly traded Healthcare sector company. As of May 21, 2026, UPC trades at $2.76 with a market cap of $1.45M and a P/E ratio of 0.00. UPC moved +0.00% today. Year to date, UPC is -33.99%; over the trailing twelve months it is -55.22%. Its 52-week range spans $2.00 to $600.00. Rallies surfaces UPC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading UPC stock inside the company?

Rallies tracks UPC insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

UPC Key Metrics

Key financial metrics for UPC
MetricValue
Price$2.76
Market Cap$1.45M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.33%
52-Week High$600.00
52-Week Low$2.00
Volume3
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest UPC News

UPC Analyst Consensus

UPC analyst coverage data. Average price target: $0.00.

Common questions about UPC

Who is trading UPC stock inside the company?
Rallies tracks UPC insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for UPC?
Yes. Rallies tracks UPC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is UPC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UPC. It does not provide personalized investment advice.
UPC

UPC